These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 7126306)
1. [Histopathology of bilharziasis]. Loubiere R; Ette M Ann Pathol; 1982; 2(3):191-7. PubMed ID: 7126306 [TBL] [Abstract][Full Text] [Related]
2. [Anatomopathological aspects of schistosomiasis. A study of 286 pathological specimens. (author's transl)]. Ricosse JH; Emeric R; Courbil LJ Med Trop (Mars); 1980; 40(1):77-94. PubMed ID: 7366368 [TBL] [Abstract][Full Text] [Related]
3. [Historical aspects of the risk factors of Schistosoma intercalatum schistosomiasis]. Jusot JF; Simarro P; De Muynck A Sante; 1996; 6(3):165-72. PubMed ID: 8764451 [TBL] [Abstract][Full Text] [Related]
4. The shrinking schistosomal egg granuloma: how accessory cells control T cell-mediated pathology. Stadecker MJ Exp Parasitol; 1994 Sep; 79(2):198-201. PubMed ID: 8056081 [No Abstract] [Full Text] [Related]
5. Reverse genetics and the study of the immune response to schistosomes. Pearce EJ; Freitas TC Parasite Immunol; 2008 Apr; 30(4):215-21. PubMed ID: 18324924 [TBL] [Abstract][Full Text] [Related]
6. Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies? Abath FG; Morais CN; Montenegro CE; Wynn TA; Montenegro SM Trends Parasitol; 2006 Feb; 22(2):85-91. PubMed ID: 16380294 [TBL] [Abstract][Full Text] [Related]
7. Granulomas are not just gizmos for immunologists. Doenhoff MJ Trends Immunol; 2003 Apr; 24(4):168-9; author reply 169-70. PubMed ID: 12697442 [No Abstract] [Full Text] [Related]
8. Current status and future prospects for a vaccine against schistosomiasis. Lebens M; Sun JB; Czerkinsky C; Holmgren J Expert Rev Vaccines; 2004 Jun; 3(3):315-28. PubMed ID: 15176948 [TBL] [Abstract][Full Text] [Related]
9. [Synthesis of immunity phenomena and immunopathology in bilharziasis. Consequences for man in endemic areas]. Nozais JP Med Trop (Mars); 1982; 42(6):637-40. PubMed ID: 7154911 [No Abstract] [Full Text] [Related]
10. Immunologic basis of disease and disease regulation in schistosomiasis. Cheever AW; Yap GS Chem Immunol; 1997; 66():159-76. PubMed ID: 9103669 [No Abstract] [Full Text] [Related]
11. Schistosomiasis. Infection versus disease and hypersensitivity versus immunity. Cheever AW Am J Pathol; 1993 Mar; 142(3):699-702. PubMed ID: 8456933 [No Abstract] [Full Text] [Related]
13. A contributory role for activated hepatic stellate cells in the dynamics of Schistosoma japonicum egg-induced fibrosis. Bartley PB; Ramm GA; Jones MK; Ruddell RG; Li Y; McManus DP Int J Parasitol; 2006 Aug; 36(9):993-1001. PubMed ID: 16806222 [TBL] [Abstract][Full Text] [Related]
14. [Evolution of hepatic periovular granulomas in different types of repeated infections with S. mansoni in mice (author's transl)]. Abouzkham AA; Buttner A Ann Parasitol Hum Comp; 1980; 55(2):199-207. PubMed ID: 7458158 [TBL] [Abstract][Full Text] [Related]
17. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Capron A; Riveau G; Capron M; Trottein F Trends Parasitol; 2005 Mar; 21(3):143-9. PubMed ID: 15734662 [TBL] [Abstract][Full Text] [Related]
18. Schistosoma mekongi: a prominent neutrophil chemotactic activity of egg antigen with reference to that of Schistosoma japonicum. Owhashi M; Matsumoto J; Imase A; Kirinoki M; Kitikoon V; Chigusa Y; Matsuda H Exp Parasitol; 2005 Aug; 110(4):335-41. PubMed ID: 15893311 [TBL] [Abstract][Full Text] [Related]
20. Development of a vaccine strategy against human and bovine schistosomiasis. Background and update. Capron A; Riveau G; Grzych JM; Boulanger D; Capron M; Pierce R Trop Geogr Med; 1994; 46(4 Spec No):242-6. PubMed ID: 7825228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]